Commonwealth Equity Services, LLC Durect Corp Transaction History

Commonwealth Equity Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	BUY	$0.9 - $1.31 $900 - $1,310	1,000 Added 4.55%	22,955 $22,000
Q4 2020 Feb 11, 2021	BUY	$1.65 - $2.43 $13,200 - $19,440	8,000 Added 57.33%	21,955 $45,000
Q1 2020 May 11, 2020	SELL	$0.97 - $2.85 $1,940 - $5,700	-2,000 Reduced 12.54%	13,955 $21,000
Q4 2019 Feb 05, 2020	SELL	$1.69 - $3.8 $16,900 - $38,000	-10,000 Reduced 38.53%	15,955 $60,000
Q3 2019 Oct 30, 2019	BUY	$0.61 - $2.21 $4,270 - $15,470	7,000 Added 36.93%	25,955 $47,000
Q2 2019 Jul 19, 2019	BUY	$0.51 - $0.86 $3,292 - $5,551	6,455 Added 51.64%	18,955 $12,000
Q1 2019 May 13, 2019	BUY	$0.51 - $0.82 $1,275 - $2,050	2,500 Added 25.0%	12,500 $7,000
Q3 2018 Nov 06, 2018	SELL	$1.06 - $1.69 $5,830 - $9,295	-5,500 Reduced 35.48%	10,000 $11,000
Q2 2018 Jul 31, 2018	SELL	$1.56 - $2.51 $7,800 - $12,549	-5,000 Reduced 24.39%	15,500 $24,000
Q1 2018 May 14, 2018	SELL	$0.91 - $2.24 $2,275 - $5,600	-2,500 Reduced 10.87%	20,500 $43,000
Q4 2017 Feb 12, 2018	BUY	$0.78 - $2.1 $17,940 - $48,300	23,000	23,000 $21,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.